Joshua J. Solano
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Joshua J. Solano has a total of 78 co-authors. Here are the top co-authors by number of shared publications:
- Richard D. Shih
Department of Emergency Medicine, Charles E. Schmidt College of Medicine, Florida Atlantic University, 777 Glades Road, Boca Raton, FL 33431, USA
14 shared publications - Scott M. Alter
Department of Emergency Medicine, Florida Atlantic University Charles E. Schmidt College of Medicine, Boca Raton, Florida, USA
14 shared publications - Patrick G. Hughes
Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City, UT, USA
11 shared publications - Lisa M. Clayton
Department of Emergency Medicine, Florida Atlantic University Charles E. Schmidt College of Medicine, Boca Raton, USA
7 shared publications - Gabriella Engstrom
Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, USA
4 shared publications - Lisa M. Clayton
Charles E. Schmidt College of Medicine Florida Atlantic University Boca Raton Florida USA
4 shared publications
Latest Publications
- Open Access
- 10 February 2026
- Published by Elsevier in SSRN Electronic Journal
Not ideal and poorly adjusted: the case against ideal body weight and adjusted body weight as drug dose scalars in obese adults
BackgroundIn obese adult patients, estimates of ideal body weight (IBW) or adjusted body weight (AdjBW) are often used as drug dose scalars. Many formulas for estimating IBW have been derived, but it is not known which, if any, is the most appropriate as a dose scalar. The objective of this study was to assess the association of methods of estimating IBW and AdjBW with measured body composition in obese adults.MethodsThis was a secondary analysis of an existing dataset. A pooled dataset from the United States’ National Health and Nutrition Examination Surveys, including adults with a BMI ≥30kg/m2 (n=10,606), was used to evaluate methods of estimating IBW and AdjBW. The estimates were evaluated against measured lean body weight (LBW). The primary outcome measure was the proportion of IBW or AdjBW estimates within 10% and 20% of measured LBW (P10 and P20), used as an indicator of the strength of association with body composition.ResultsSeventeen methods of estimating IBW, and one method of estimating AdjBW, were identified. None of these methods were found to have a consistent association with LBW. P10s for male participants varied from 56.4% to 72.7% and for females from 23.1% to 57.7%. Performance of the formulas was also very inconsistent between BMI classes.ConclusionsWeight-based drug doses calculated using IBW or AdjBW cannot be consistent with body composition: some patients will be underdosed and others overdosed. Although IBW and AdjBW are commonly used in clinical practice, their use as dose scalars should be reconsidered.
- 10 February 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessNot ideal and poorly adjusted: the case against ideal body weight and adjusted body weight as drug dose scalars in obese adults
BackgroundIn obese adult patients, estimates of ideal body weight (IBW) or adjusted body weight (AdjBW) are often used as drug dose scalars. Many formulas for estimating IBW have been derived, but it is not known which, if any, is the most appropriate as a dose scalar. The objective of this study was to assess the association of methods of estimating IBW and AdjBW with measured body composition in obese adults.MethodsThis was a secondary analysis of an existing dataset. A pooled dataset from the United States’ National Health and Nutrition Examination Surveys, including adults with a BMI ≥30kg/m2 (n=10,606), was used to evaluate methods of estimating IBW and AdjBW. The estimates were evaluated against measured lean body weight (LBW). The primary outcome measure was the proportion of IBW or AdjBW estimates within 10% and 20% of measured LBW (P10 and P20), used as an indicator of the strength of association with body composition.ResultsSeventeen methods of estimating IBW, and one method of estimating AdjBW, were identified. None of these methods were found to have a consistent association with LBW. P10s for male participants varied from 56.4% to 72.7% and for females from 23.1% to 57.7%. Performance of the formulas was also very inconsistent between BMI classes.ConclusionsWeight-based drug doses calculated using IBW or AdjBW cannot be consistent with body composition: some patients will be underdosed and others overdosed. Although IBW and AdjBW are commonly used in clinical practice, their use as dose scalars should be reconsidered.
- Open Access
- 26 September 2025
- Published by California Digital Library (CDL) in Western Journal of Emergency Medicine
- Vol. 26 (5) , 1414-1422
Pharmacogenomic Drug-Gene Interactions in Geriatric Emergency Department Patients Who Sustained Falls: A Pilot Study
Introduction: Pharmacogenomic-assisted prescribing of medications uses individual genetic information to identify drug-gene interactions. We aimed to assess potential pharmacogenomic drug-gene interactions in geriatric emergency department (ED) patients who sustained a fall. Methods: This was a prospective study involving 25 older adult ED patients with fall-related injury. Data collected included current medications, demographics, and mechanism of injury. All patients provided a DNA sample, which underwent pharmacogenomic testing by an accredited genetics lab, Each patient’s medications were reviewed against their pharmacogenomic report and categorized as Green (continue to use), Yellow (use with caution) or Red (stop use) based on their genetic information and published interactions by the Clinical Pharmacogenetics Implementation Consortium, Dutch Pharmacogenetics Working Group, and US Food and Drug Administration-approved drug label information. The main study outcome was pharmacogenomic drug-gene interactions. Results: Of the 25 patients enrolled (median age, 81 years, IQR 76-85), 68% were female. Patients were taking a median of eight medications (IQR 5-11). The most common types were antihypertensives, statins, anticoagulants, and anti-platelet medications. Significant drug-gene interactions (Yellow or Red) were identified in 14/25 patients (56%; 95% CI 35-76%). Further, 6/25 (24%; 95% CI 9-45%) had one or more potentially serious (Red) interactions identified. Conclusion: We found that in geriatric ED patients with a fall-related injury, most had a significant pharmacogenomic drug-gene interaction. DNA testing identifies these interactions and can assist with pharmacogenomic-guided medication prescribing, which may decrease adverse drug events and improve clinical outcomes.
- 26 September 2025
- Published by California Digital Library (CDL) in Western Journal of Emergency Medicine
- Vol. 26 (5) , 1414-1422
Open AccessPharmacogenomic Drug-Gene Interactions in Geriatric Emergency Department Patients Who Sustained Falls: A Pilot Study
Introduction: Pharmacogenomic-assisted prescribing of medications uses individual genetic information to identify drug-gene interactions. We aimed to assess potential pharmacogenomic drug-gene interactions in geriatric emergency department (ED) patients who sustained a fall. Methods: This was a prospective study involving 25 older adult ED patients with fall-related injury. Data collected included current medications, demographics, and mechanism of injury. All patients provided a DNA sample, which underwent pharmacogenomic testing by an accredited genetics lab, Each patient’s medications were reviewed against their pharmacogenomic report and categorized as Green (continue to use), Yellow (use with caution) or Red (stop use) based on their genetic information and published interactions by the Clinical Pharmacogenetics Implementation Consortium, Dutch Pharmacogenetics Working Group, and US Food and Drug Administration-approved drug label information. The main study outcome was pharmacogenomic drug-gene interactions. Results: Of the 25 patients enrolled (median age, 81 years, IQR 76-85), 68% were female. Patients were taking a median of eight medications (IQR 5-11). The most common types were antihypertensives, statins, anticoagulants, and anti-platelet medications. Significant drug-gene interactions (Yellow or Red) were identified in 14/25 patients (56%; 95% CI 35-76%). Further, 6/25 (24%; 95% CI 9-45%) had one or more potentially serious (Red) interactions identified. Conclusion: We found that in geriatric ED patients with a fall-related injury, most had a significant pharmacogenomic drug-gene interaction. DNA testing identifies these interactions and can assist with pharmacogenomic-guided medication prescribing, which may decrease adverse drug events and improve clinical outcomes.
- Open Access
- 10 July 2025
- Published by Hapres in Advances in Geriatric Medicine and Research
- Vol. 7 (3)
Lack of Fall Concern and Primary Care Physician Follow-Up in Geriatric Emergency Department Patients with Head Trauma from a Fall
Background: Falls are the leading cause of fatal and nonfatal injuries in the United States for adults aged 65 years and older. The objective of this study was to determine the impact of patient self-perceived concern about falling on subsequent primary care provider (PCP) follow-up in older emergency department (ED) adults who sustained a head injury from a fall. Methods: This was a secondary analysis of a large prospective study which included patients aged ≥65 years who had sustained head trauma from a fall. Patients with penetrating injuries, injury >24 h prior to presentation, and transfer from another hospital were excluded. Participants were telephonically followed up 14 days after ED presentation. They were asked about their concern for a repeat fall and whether they had followed-up with their PCP since discharge. Results: Of 1527 participants surveyed, 769 (50.4%) were concerned about falling again and 758 (49.6%) were slightly or not at all concerned. There was an overall low PCP follow-up rate. The follow up rate was slightly higher for those concerned vs. not concerned about falling (62% vs 56%, p = 0.035; OR = 1.25, 95% CI: 1.01–1.53). Conclusions: Geriatric ED patients who suffered head injury from a fall and expressed concern about future falls were more likely to follow up with their PCP. Fifty percent of participants with a self-reported fall expressed little to no concern for falling again. This suggests that many ED patients that have fallen are vulnerable to deficient PCP follow-up and fall prevention strategies. We suggest increased physician and patient education to emphasize fall prevention and PCP follow-up.
- 10 July 2025
- Published by Hapres in Advances in Geriatric Medicine and Research
- Vol. 7 (3)
Open AccessLack of Fall Concern and Primary Care Physician Follow-Up in Geriatric Emergency Department Patients with Head Trauma from a Fall
Background: Falls are the leading cause of fatal and nonfatal injuries in the United States for adults aged 65 years and older. The objective of this study was to determine the impact of patient self-perceived concern about falling on subsequent primary care provider (PCP) follow-up in older emergency department (ED) adults who sustained a head injury from a fall. Methods: This was a secondary analysis of a large prospective study which included patients aged ≥65 years who had sustained head trauma from a fall. Patients with penetrating injuries, injury >24 h prior to presentation, and transfer from another hospital were excluded. Participants were telephonically followed up 14 days after ED presentation. They were asked about their concern for a repeat fall and whether they had followed-up with their PCP since discharge. Results: Of 1527 participants surveyed, 769 (50.4%) were concerned about falling again and 758 (49.6%) were slightly or not at all concerned. There was an overall low PCP follow-up rate. The follow up rate was slightly higher for those concerned vs. not concerned about falling (62% vs 56%, p = 0.035; OR = 1.25, 95% CI: 1.01–1.53). Conclusions: Geriatric ED patients who suffered head injury from a fall and expressed concern about future falls were more likely to follow up with their PCP. Fifty percent of participants with a self-reported fall expressed little to no concern for falling again. This suggests that many ED patients that have fallen are vulnerable to deficient PCP follow-up and fall prevention strategies. We suggest increased physician and patient education to emphasize fall prevention and PCP follow-up.
- 3 July 2024
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 72 (9) , 2738-2751
The Florida Geriatric Head Trauma CT Clinical Decision Rule
Background: Several clinical decision rules have been devised to guide head computed tomography (CT) use in patients with minor head injuries, but none have been validated in patients 65 years or older. We aimed to derive and validate a head injury clinical decision rule for older adults. Methods: We conducted a secondary analysis of an existing dataset of consecutive emergency department (ED) patients >65 years old with blunt head trauma. The main predictive outcomes were significant intracranial injury and Need for Neurosurgical Intervention on CT. The secondary outcomes also considered in the model development and validation were All Injuries and All Intracranial Injuries. Predictor variables were identified using multiple variable logistic regression, and clinical decision rule models were developed in a split‐sample derivation cohort and then tested in an independent validation cohort. Results: Of 5776 patients, 233 (4.0%) had significant intracranial injury and an additional 104 (1.8%) met CT criteria for Need for Neurosurgical Intervention. The best performing model, the Florida Geriatric Head Trauma CT Clinical Decision Rule, assigns points based on several clinical variables. If the points totaled 25 or more, a CT scan is indicated. The included predictors were arrival via Emergency Medical Services (+30 points), Glasgow Coma Scale (GCS) <15 (+20 points), GCS <14 (+50 points), antiplatelet medications (+17 points), loss of consciousness (+16 points), signs of basilar skull fracture (+50 points), and headache (+20 points). Utilizing this clinical decision rule in the validation cohort, a point total ≥25 had a sensitivity and specificity of 100.0% (95% CI: 96.0–100) and 12.3% (95% CI: 10.9–13.8), respectively, for significant intracranial injury and Need for Neurosurgical Intervention. Conclusions: The Florida Geriatric Head Trauma CT Clinical Decision Rule has the potential to reduce unnecessary CT scans in older adults, without compromising safe emergency medicine practice.
- 3 July 2024
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 72 (9) , 2738-2751
The Florida Geriatric Head Trauma CT Clinical Decision Rule
Background: Several clinical decision rules have been devised to guide head computed tomography (CT) use in patients with minor head injuries, but none have been validated in patients 65 years or older. We aimed to derive and validate a head injury clinical decision rule for older adults. Methods: We conducted a secondary analysis of an existing dataset of consecutive emergency department (ED) patients >65 years old with blunt head trauma. The main predictive outcomes were significant intracranial injury and Need for Neurosurgical Intervention on CT. The secondary outcomes also considered in the model development and validation were All Injuries and All Intracranial Injuries. Predictor variables were identified using multiple variable logistic regression, and clinical decision rule models were developed in a split‐sample derivation cohort and then tested in an independent validation cohort. Results: Of 5776 patients, 233 (4.0%) had significant intracranial injury and an additional 104 (1.8%) met CT criteria for Need for Neurosurgical Intervention. The best performing model, the Florida Geriatric Head Trauma CT Clinical Decision Rule, assigns points based on several clinical variables. If the points totaled 25 or more, a CT scan is indicated. The included predictors were arrival via Emergency Medical Services (+30 points), Glasgow Coma Scale (GCS) <15 (+20 points), GCS <14 (+50 points), antiplatelet medications (+17 points), loss of consciousness (+16 points), signs of basilar skull fracture (+50 points), and headache (+20 points). Utilizing this clinical decision rule in the validation cohort, a point total ≥25 had a sensitivity and specificity of 100.0% (95% CI: 96.0–100) and 12.3% (95% CI: 10.9–13.8), respectively, for significant intracranial injury and Need for Neurosurgical Intervention. Conclusions: The Florida Geriatric Head Trauma CT Clinical Decision Rule has the potential to reduce unnecessary CT scans in older adults, without compromising safe emergency medicine practice.
- Open Access
- 23 October 2023
- Published by Springer Nature in Cureus
- Vol. 15 (10) , e47509
Transient Hypoglossal and Lingual Nerve Injury Following the Use of I-gel Supraglottic Airway: A Case Report
Injury to the hypoglossal and/or lingual nerve is a rare occurrence with the use of a laryngeal mask airway (LMA) or supraglottic airway (SGA) device. There has been one prior report of a lingual and hypoglossal nerve injury with the i-gel™ SGA. We are describing the second reported hypoglossal and lingual transient nerve injury in a male patient while using an i-gel™ SGA. Although excessive cuff pressure has been cited as a possible cause, the i-gel™ does not have a cuff. This report highlights that hypoglossal nerve injury can still occur, even with the use of a cuffless LMA such as the i-gel™ SGA.
- 23 October 2023
- Published by Springer Nature in Cureus
- Vol. 15 (10) , e47509
Open AccessTransient Hypoglossal and Lingual Nerve Injury Following the Use of I-gel Supraglottic Airway: A Case Report
Injury to the hypoglossal and/or lingual nerve is a rare occurrence with the use of a laryngeal mask airway (LMA) or supraglottic airway (SGA) device. There has been one prior report of a lingual and hypoglossal nerve injury with the i-gel™ SGA. We are describing the second reported hypoglossal and lingual transient nerve injury in a male patient while using an i-gel™ SGA. Although excessive cuff pressure has been cited as a possible cause, the i-gel™ does not have a cuff. This report highlights that hypoglossal nerve injury can still occur, even with the use of a cuffless LMA such as the i-gel™ SGA.
- Open Access
- 20 October 2023
- Published by California Digital Library (CDL) in Clinical Practice and Cases in Emergency Medicine
- Vol. 7 (4) , 230-233
Cerebellar Infarction from a Vertebral Artery Dissection after Blunt Chest Injury: A Case Report
Introduction: Traumatic vertebral artery dissections resulting in stroke are relatively rare occurrences, especially in the absence of classic physical examination findings.Case Report: We present the case of a 30-year-old male with chest pain following a car axle falling onto his chest while trying to change a tire. He was discharged from the emergency department after having a negative workup for thoracic injury. Six hours later, the patient returned with headache and was found to have a cerebellar stroke secondary to vertebral artery dissection. After hospitalization, the patient was discharged home without any neurological deficits.Conclusion: As they are usually asymptomatic, up to 80% of patients with blunt cerebrovascular injury will have delayed or missed diagnoses. Given the increased awareness of vascular injuries and their high morbidity, physicians should maintain a high index of suspicion for this diagnosis.
- 20 October 2023
- Published by California Digital Library (CDL) in Clinical Practice and Cases in Emergency Medicine
- Vol. 7 (4) , 230-233
Open AccessCerebellar Infarction from a Vertebral Artery Dissection after Blunt Chest Injury: A Case Report
Introduction: Traumatic vertebral artery dissections resulting in stroke are relatively rare occurrences, especially in the absence of classic physical examination findings.Case Report: We present the case of a 30-year-old male with chest pain following a car axle falling onto his chest while trying to change a tire. He was discharged from the emergency department after having a negative workup for thoracic injury. Six hours later, the patient returned with headache and was found to have a cerebellar stroke secondary to vertebral artery dissection. After hospitalization, the patient was discharged home without any neurological deficits.Conclusion: As they are usually asymptomatic, up to 80% of patients with blunt cerebrovascular injury will have delayed or missed diagnoses. Given the increased awareness of vascular injuries and their high morbidity, physicians should maintain a high index of suspicion for this diagnosis.
- 4 January 2023
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 65, 168-171
Comparing rates of skull fractures in female versus male geriatric patients who sustain head injuries
- 4 January 2023
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 65, 168-171
Comparing rates of skull fractures in female versus male geriatric patients who sustain head injuries
- Open Access
- 22 December 2022
- Published by Springer Nature in Cureus
- Vol. 14 (12)
The Role of Thromboelastography in Identifying Coagulopathy Among Geriatric Traumatic Brain Injury Patients
Background The geriatric population has the highest incidence of head injury, and those who are anticoagulated have an increased risk of traumatic intracranial hemorrhage (ICH). The availability of viscoelastic coagulation studies has coincided with the development of many anticoagulation reversal agents. In this study, our objective was to assess whether the thromboelastography (TEG) assay affected clinical decision-making regarding reversal agent administration among geriatric patients with ICH caused by blunt head trauma. Methodology We prospectively screened adults aged 65 and older with head trauma presenting to the emergency departments of two level-one trauma centers. International Classification of Diseases, Tenth Revision codes S00-09 were used to identify the diagnosis of head injury. Patients with CT head imaging positive for acute ICH were included. Each patient was assessed for home use of antiplatelet or anticoagulant medications, as well as in-hospital use of any reversal agents. Reversal agent administration and mortality were compared between patients who received TEG and those who did not. Results A total of 680 patients had acute ICH on head CT, and 324 (48%) patients received TEG. More patients screened with TEG were transfused platelets (30.2% vs. 10.7%, p < 0.001). This remained significant for patients taking anticoagulants, antiplatelets, or neither. There were no differences in the administration of other reversal agents (prothrombin complex concentrate or fresh frozen plasma) or mortality whether or not TEG was performed. Conclusions Patients who had TEG performed were more likely to receive platelet reversal agents, regardless of antiplatelet medication usage. Among elderly adults with ICH, TEG is a rapid screening test that may help identify patients with platelet function abnormalities requiring reversal.
- 22 December 2022
- Published by Springer Nature in Cureus
- Vol. 14 (12)
Open AccessThe Role of Thromboelastography in Identifying Coagulopathy Among Geriatric Traumatic Brain Injury Patients
Background The geriatric population has the highest incidence of head injury, and those who are anticoagulated have an increased risk of traumatic intracranial hemorrhage (ICH). The availability of viscoelastic coagulation studies has coincided with the development of many anticoagulation reversal agents. In this study, our objective was to assess whether the thromboelastography (TEG) assay affected clinical decision-making regarding reversal agent administration among geriatric patients with ICH caused by blunt head trauma. Methodology We prospectively screened adults aged 65 and older with head trauma presenting to the emergency departments of two level-one trauma centers. International Classification of Diseases, Tenth Revision codes S00-09 were used to identify the diagnosis of head injury. Patients with CT head imaging positive for acute ICH were included. Each patient was assessed for home use of antiplatelet or anticoagulant medications, as well as in-hospital use of any reversal agents. Reversal agent administration and mortality were compared between patients who received TEG and those who did not. Results A total of 680 patients had acute ICH on head CT, and 324 (48%) patients received TEG. More patients screened with TEG were transfused platelets (30.2% vs. 10.7%, p < 0.001). This remained significant for patients taking anticoagulants, antiplatelets, or neither. There were no differences in the administration of other reversal agents (prothrombin complex concentrate or fresh frozen plasma) or mortality whether or not TEG was performed. Conclusions Patients who had TEG performed were more likely to receive platelet reversal agents, regardless of antiplatelet medication usage. Among elderly adults with ICH, TEG is a rapid screening test that may help identify patients with platelet function abnormalities requiring reversal.
- Open Access
- 1 December 2022
- Published by Cambridge University Press (CUP) in American Journal of Law & Medicine
- Vol. 48 (4) , 412-419
Pelvic Exam Laws in the United States: A Systematic Review
Laws regulating patient care are an essential component of protecting patients and doctors alike. No studies have previously examined what laws exist regarding pelvic examinations in the United States (US). This study systematically reviews and compares regulation and legislation of pelvic examinations in the U.S. and provides a comprehensive resource to educate clinicians, patients, and lawmakers. Each of the fifty States in the U.S. was included. The primary outcome was existence of any pelvic or rectal exam laws. Data was obtained for the type of examination defined within the law, exceptions to the law, to whom the law applied to, the type of consent required, and to whom the consent applied to. Laws were identified from each of the individual state legislative websites. All sections of each law pertaining to pelvic examination were reviewed and organized by state. Descriptive statistics were performed for each of the variables, including frequencies of each amongst the fifty states. State regulation for pelvic examinations varied from no law or regulation to laws pertaining to pelvic, rectal, prostate, and breast examination performed in any context. As of November 22, 2022, there are twenty states (40%) with pelvic examination laws applying to anesthetized or unconscious patients. Thirteen additional states (26%) have proposed pelvic exam laws. Seventeen states (34%) do not have any laws regarding pelvic examinations. Regulation of pelvic examinations has become an increasingly important issue over the past few years in response to growing concerns of patient autonomy and the ethical issues raised by such sensitive examinations. While pelvic examination laws that balance protection for patient autonomy and the needs of caregivers and educators exist in much of the U.S., more work needs to continue in consultation with physicians and health care providers to ensure that all states have reasonable laws protecting the autonomy of patients while also maintaining quality of care.
- 1 December 2022
- Published by Cambridge University Press (CUP) in American Journal of Law & Medicine
- Vol. 48 (4) , 412-419
Open AccessPelvic Exam Laws in the United States: A Systematic Review
Laws regulating patient care are an essential component of protecting patients and doctors alike. No studies have previously examined what laws exist regarding pelvic examinations in the United States (US). This study systematically reviews and compares regulation and legislation of pelvic examinations in the U.S. and provides a comprehensive resource to educate clinicians, patients, and lawmakers. Each of the fifty States in the U.S. was included. The primary outcome was existence of any pelvic or rectal exam laws. Data was obtained for the type of examination defined within the law, exceptions to the law, to whom the law applied to, the type of consent required, and to whom the consent applied to. Laws were identified from each of the individual state legislative websites. All sections of each law pertaining to pelvic examination were reviewed and organized by state. Descriptive statistics were performed for each of the variables, including frequencies of each amongst the fifty states. State regulation for pelvic examinations varied from no law or regulation to laws pertaining to pelvic, rectal, prostate, and breast examination performed in any context. As of November 22, 2022, there are twenty states (40%) with pelvic examination laws applying to anesthetized or unconscious patients. Thirteen additional states (26%) have proposed pelvic exam laws. Seventeen states (34%) do not have any laws regarding pelvic examinations. Regulation of pelvic examinations has become an increasingly important issue over the past few years in response to growing concerns of patient autonomy and the ethical issues raised by such sensitive examinations. While pelvic examination laws that balance protection for patient autonomy and the needs of caregivers and educators exist in much of the U.S., more work needs to continue in consultation with physicians and health care providers to ensure that all states have reasonable laws protecting the autonomy of patients while also maintaining quality of care.
- Open Access
- 17 September 2022
- Published by Springer Nature in Cureus
- Vol. 14 (9) , e29247
The Treatment of COVID-19 With Monoclonal Antibody Therapy: Patient-Reported Outcomes
There have been many efforts to research and produce treatment modalities for COVID-19. Monoclonal antibodies have been one of the effective treatments since their approval by the US Food and Drug Administration (FDA) under emergency use authorization (EUA) in 2020. This study surveyed COVID-19 patients about their disease course and experience with monoclonal antibody treatment. Patients who received monoclonal antibody treatment between February 12, 2021, and June 2, 2021, at a South Florida community hospital were enrolled in the study. This included patients over 18 years of age with a confirmed positive COVID-19 test result, with mild to moderate symptoms within 10 days of onset and identified as high risk for progression to severe disease. There were no exclusion criteria. After 30 days, patients were followed up via a structured telephone survey regarding subsequent emergency department (ED) visits for worsening COVID-19 symptoms, need for oxygenation, intubation, and death. Secondary outcomes were adverse effects and patient perceptions. Among the 119 patients who received monoclonal antibodies during the established time frame, 93 (78.1%) consented to participate in the telephone survey. Of these, 11.8% had a subsequent visit to the ED for worsening COVID-19 symptoms, 6.5% required oxygen, and 2.2% were admitted to the intensive care unit (ICU). There were no reported intubations or deaths. The vast majority (91.4%) would recommend monoclonal antibody treatment to others. Patients who received monoclonal antibody therapy had low rates of subsequent ED visits and rarely required oxygen or ICU admission. The majority of patients would recommend treatment with monoclonal antibodies to others.
- 17 September 2022
- Published by Springer Nature in Cureus
- Vol. 14 (9) , e29247
Open AccessThe Treatment of COVID-19 With Monoclonal Antibody Therapy: Patient-Reported Outcomes
There have been many efforts to research and produce treatment modalities for COVID-19. Monoclonal antibodies have been one of the effective treatments since their approval by the US Food and Drug Administration (FDA) under emergency use authorization (EUA) in 2020. This study surveyed COVID-19 patients about their disease course and experience with monoclonal antibody treatment. Patients who received monoclonal antibody treatment between February 12, 2021, and June 2, 2021, at a South Florida community hospital were enrolled in the study. This included patients over 18 years of age with a confirmed positive COVID-19 test result, with mild to moderate symptoms within 10 days of onset and identified as high risk for progression to severe disease. There were no exclusion criteria. After 30 days, patients were followed up via a structured telephone survey regarding subsequent emergency department (ED) visits for worsening COVID-19 symptoms, need for oxygenation, intubation, and death. Secondary outcomes were adverse effects and patient perceptions. Among the 119 patients who received monoclonal antibodies during the established time frame, 93 (78.1%) consented to participate in the telephone survey. Of these, 11.8% had a subsequent visit to the ED for worsening COVID-19 symptoms, 6.5% required oxygen, and 2.2% were admitted to the intensive care unit (ICU). There were no reported intubations or deaths. The vast majority (91.4%) would recommend monoclonal antibody treatment to others. Patients who received monoclonal antibody therapy had low rates of subsequent ED visits and rarely required oxygen or ICU admission. The majority of patients would recommend treatment with monoclonal antibodies to others.